We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRGI
10751
PUT
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$172K ﹤0.01%
24,100
-9,900
-29% -$70K
BCSF icon
10752
CALL
Bain Capital Specialty
BCSF
$814M
$171K ﹤0.01%
+12,600
New +$188K
PXLW icon
10753
CALL
Pixelworks
PXLW
$42.2M
$171K ﹤0.01%
7,467
-2,166
-22% -$56.1K
NSLR
10754
Neostellar Capital Corp
NSLR
$278M
$171K ﹤0.01%
+26,686
New +$206K
CWAN
10755
CALL
DELISTED
Clearwater Analytics
CWAN
$170K ﹤0.01%
+14,100
New +$228K
AKTS
10756
DELISTED
Akoustis Technologies Inc
AKTS
$170K ﹤0.01%
46,055
-10,030
-18% -$44.4K
BTTX
10757
CALL
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$170K ﹤0.01%
108,900
+12,300
+13% +$20.6K
ALTO icon
10758
CALL
Alto Ingredients
ALTO
$324M
$169K ﹤0.01%
45,500
-20,200
-31% -$106K
BLZE icon
10759
Backblaze
BLZE
$1.18B
$169K ﹤0.01%
+32,328
New +$243K
HYMC icon
10760
Hycroft Mining Holding Corp
HYMC
$2.52B
$169K ﹤0.01%
15,232
-10,548
-41% -$156K
MDXG icon
10761
PUT
MiMedx Group
MDXG
$622M
$169K ﹤0.01%
48,600
+13,100
+37% +$51.3K
VOC icon
10762
CALL
VOC Energy
VOC
$53.9M
$169K ﹤0.01%
26,100
-12,600
-33% -$93.1K
TVRD
10763
PUT
Tvardi Therapeutics
TVRD
$25.3M
$169K ﹤0.01%
514
+89
+21% +$31.2K
DFH icon
10764
PUT
Dream Finders Homes
DFH
$1.42B
$168K ﹤0.01%
+15,800
New +$250K
KG
10765
Kestrel Group
KG
$61.7M
$168K ﹤0.01%
+4,334
New +$194K
STRO icon
10766
PUT
Sutro Biopharma
STRO
$340M
$168K ﹤0.01%
+3,230
New +$180K
WEBL icon
10767
PUT
Direxion Daily Dow Jones Internet Bull 3X ETF
WEBL
$109M
$168K ﹤0.01%
+20,800
New +$327K
APGB.U
10768
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
$168K ﹤0.01%
16,990
+240
+1% +$2.37K
CCV.U
10769
DELISTED
Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable warrant
CCV.U
$168K ﹤0.01%
16,910
-608
-3% -$6.05K
DBTX
10770
PUT
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$168K ﹤0.01%
+39,900
New +$94.3K
CRMD icon
10771
PUT
CorMedix
CRMD
$588M
$167K ﹤0.01%
41,600
+600
+1% +$2.23K
SKYT
10772
CALL
DELISTED
SkyWater Technology
SKYT
$167K ﹤0.01%
27,800
-49,600
-64% -$340K
ISUN
10773
CALL
DELISTED
iSun, Inc. Common Stock
ISUN
$167K ﹤0.01%
51,500
+11,300
+28% +$38.1K
HHR
10774
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$167K ﹤0.01%
87,334
AWRE icon
10775
CALL
Aware
AWRE
$26.4M
$166K ﹤0.01%
69,800
-11,800
-14% -$31.3K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.